CBD Review
346
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | December 2025 | 0 |
| January 2026 | 0 | |
| February 2026 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About CBD
The entity associated with the domain cbdmarkets.net has been the subject of a warning issued by the Financial Conduct Authority (FCA) in the United Kingdom. According to the FCA notice, a firm using this domain was identified as an unauthorised entity and a clone of an FCA-authorised company. The regulator explicitly stated that there is no connection between the unauthorised website and the legitimate firm it impersonated. The FCA record lists this domain as part of the fraudulent operation and confirms that it lacks any authorisation to offer investment or brokerage services in the UK.
The FCA warning includes full details of the legitimate company being cloned, along with its authorised Financial Services Register number, and clarifies that consumers dealing with cbdmarkets.net will not have access to the Financial Ombudsman Service or the Financial Services Compensation Scheme protections. There are no publicly verified licences or registrations for the brand βCBDβ under major regulators such as the FCA, CySEC, ASIC, or NFA/CFTC.
